Jvion raised a significant growth equity investment led by growth equity firm JMI Equity. Additional investors include Health Enterprise Partners and Health Velocity Capital, two leading healthcare investment firms.
Founded in 2011, Jvion developed the Cognitive Clinical Success Machine, which uses artificial intelligence to turn healthcare data into prescriptive clinical intelligence, reducing patient-level clinical variation and improving intervention effectiveness.
Jvion plans to use the funding to accelerate expansion across the provider market and drive application of the company’s AI platform to the payor and pharmaceutical markets.